Cargando…

Optimal Perioperative Antimicrobial Management Strategies of Kidney Transplant Recipients Guided by Metagenomic Next-Generation Sequencing of Deceased Donors’ Microbiology Samples

BACKGROUND: There is no consensus on the optimal use of perioperative antibiotics prophylaxis after kidney transplantation, but there is a common trend to limit the duration of antibiotic use worldwide. Metagenomic next-generation sequencing (mNGS) has emerged as a novel technology for pathogen dete...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, Zhengsheng, Wang, Zhiling, Tang, Ming, Zhang, Keqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547004/
https://www.ncbi.nlm.nih.gov/pubmed/37795207
http://dx.doi.org/10.2147/IDR.S427656
_version_ 1785114973624598528
author Rao, Zhengsheng
Wang, Zhiling
Tang, Ming
Zhang, Keqin
author_facet Rao, Zhengsheng
Wang, Zhiling
Tang, Ming
Zhang, Keqin
author_sort Rao, Zhengsheng
collection PubMed
description BACKGROUND: There is no consensus on the optimal use of perioperative antibiotics prophylaxis after kidney transplantation, but there is a common trend to limit the duration of antibiotic use worldwide. Metagenomic next-generation sequencing (mNGS) has emerged as a novel technology for pathogen detection in clinical practice due to its noninvasive, rapid, precise and high susceptibility to detect infectious pathogens. However, data are lacking on whether mNGS analyses could be used to detect pathogens and guide anti-infection regimens in kidney transplant donors and recipients. METHODS: We conducted a retrospective study to review all clinic data of mNGS and traditional laboratory methods (TMs) for pathogen detection in kidney transplant recipients and their corresponding deceased donors from August 1, 2021 to October 30, 2022 in our center. RESULTS: A total of 57 donors and 112 of their corresponding recipients were included. The antimicrobial strategy mainly depended on mNGS results combined with traditional pathogen culture and clinical conditions. The percentages of positive pathogen detected by mNGS in blood, urine, bronchoalveolar lavage fluid (BALF) and preservation fluids (PFs) were 50.9% (29/57), 35.1% (20/57), 84.2% (48/57) and 54.4% (31/57) respectively, and were 24.6% (14/57), 15.8% (9/57), 57.9% (33/57) and 14.1% (8/57) respectively when using TMs. mNGS could detected all of pathogens which were detected by TMs. However, samples with negative TMs testing can be additionally detected as positive by mNGS (15/43 in blood, 11/48 in urine, 15/24 in BALF and 23/49 in PFs). Drug resistance genes were detected in 9 donors by mNGS,which were consistent with 6 donors by TMs. There was only one case of donor-derived infection in this study. CONCLUSION: This study showed that it is effective to combine mNGS with traditional pathogen detection methods and clinical features to develop optimal perioperative antimicrobial management strategies for deceased donor kidney transplantation.
format Online
Article
Text
id pubmed-10547004
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-105470042023-10-04 Optimal Perioperative Antimicrobial Management Strategies of Kidney Transplant Recipients Guided by Metagenomic Next-Generation Sequencing of Deceased Donors’ Microbiology Samples Rao, Zhengsheng Wang, Zhiling Tang, Ming Zhang, Keqin Infect Drug Resist Original Research BACKGROUND: There is no consensus on the optimal use of perioperative antibiotics prophylaxis after kidney transplantation, but there is a common trend to limit the duration of antibiotic use worldwide. Metagenomic next-generation sequencing (mNGS) has emerged as a novel technology for pathogen detection in clinical practice due to its noninvasive, rapid, precise and high susceptibility to detect infectious pathogens. However, data are lacking on whether mNGS analyses could be used to detect pathogens and guide anti-infection regimens in kidney transplant donors and recipients. METHODS: We conducted a retrospective study to review all clinic data of mNGS and traditional laboratory methods (TMs) for pathogen detection in kidney transplant recipients and their corresponding deceased donors from August 1, 2021 to October 30, 2022 in our center. RESULTS: A total of 57 donors and 112 of their corresponding recipients were included. The antimicrobial strategy mainly depended on mNGS results combined with traditional pathogen culture and clinical conditions. The percentages of positive pathogen detected by mNGS in blood, urine, bronchoalveolar lavage fluid (BALF) and preservation fluids (PFs) were 50.9% (29/57), 35.1% (20/57), 84.2% (48/57) and 54.4% (31/57) respectively, and were 24.6% (14/57), 15.8% (9/57), 57.9% (33/57) and 14.1% (8/57) respectively when using TMs. mNGS could detected all of pathogens which were detected by TMs. However, samples with negative TMs testing can be additionally detected as positive by mNGS (15/43 in blood, 11/48 in urine, 15/24 in BALF and 23/49 in PFs). Drug resistance genes were detected in 9 donors by mNGS,which were consistent with 6 donors by TMs. There was only one case of donor-derived infection in this study. CONCLUSION: This study showed that it is effective to combine mNGS with traditional pathogen detection methods and clinical features to develop optimal perioperative antimicrobial management strategies for deceased donor kidney transplantation. Dove 2023-09-29 /pmc/articles/PMC10547004/ /pubmed/37795207 http://dx.doi.org/10.2147/IDR.S427656 Text en © 2023 Rao et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Rao, Zhengsheng
Wang, Zhiling
Tang, Ming
Zhang, Keqin
Optimal Perioperative Antimicrobial Management Strategies of Kidney Transplant Recipients Guided by Metagenomic Next-Generation Sequencing of Deceased Donors’ Microbiology Samples
title Optimal Perioperative Antimicrobial Management Strategies of Kidney Transplant Recipients Guided by Metagenomic Next-Generation Sequencing of Deceased Donors’ Microbiology Samples
title_full Optimal Perioperative Antimicrobial Management Strategies of Kidney Transplant Recipients Guided by Metagenomic Next-Generation Sequencing of Deceased Donors’ Microbiology Samples
title_fullStr Optimal Perioperative Antimicrobial Management Strategies of Kidney Transplant Recipients Guided by Metagenomic Next-Generation Sequencing of Deceased Donors’ Microbiology Samples
title_full_unstemmed Optimal Perioperative Antimicrobial Management Strategies of Kidney Transplant Recipients Guided by Metagenomic Next-Generation Sequencing of Deceased Donors’ Microbiology Samples
title_short Optimal Perioperative Antimicrobial Management Strategies of Kidney Transplant Recipients Guided by Metagenomic Next-Generation Sequencing of Deceased Donors’ Microbiology Samples
title_sort optimal perioperative antimicrobial management strategies of kidney transplant recipients guided by metagenomic next-generation sequencing of deceased donors’ microbiology samples
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547004/
https://www.ncbi.nlm.nih.gov/pubmed/37795207
http://dx.doi.org/10.2147/IDR.S427656
work_keys_str_mv AT raozhengsheng optimalperioperativeantimicrobialmanagementstrategiesofkidneytransplantrecipientsguidedbymetagenomicnextgenerationsequencingofdeceaseddonorsmicrobiologysamples
AT wangzhiling optimalperioperativeantimicrobialmanagementstrategiesofkidneytransplantrecipientsguidedbymetagenomicnextgenerationsequencingofdeceaseddonorsmicrobiologysamples
AT tangming optimalperioperativeantimicrobialmanagementstrategiesofkidneytransplantrecipientsguidedbymetagenomicnextgenerationsequencingofdeceaseddonorsmicrobiologysamples
AT zhangkeqin optimalperioperativeantimicrobialmanagementstrategiesofkidneytransplantrecipientsguidedbymetagenomicnextgenerationsequencingofdeceaseddonorsmicrobiologysamples